- Sold by Medisafe Inc.
Free | 12 month subscription available.
This file contains a list of key terms and metrics with definitions relevant to the data products posted here.
Medisafe datasets capture medication management consumption behavior around adherence including within drug classes across different brands and granular details on scheduled dosing and reasons for non-adherence. The behavioral-driven data provides insights into healthcare consumption in a de-identified and HIPAA compliant manner. Data sourced from self-reported medication management behaviors is valuable research for the development of future healthcare advancements from drug discovery to care management and delivery programs.
Free | 12 month subscription available.
This file contains a list of key terms and metrics with definitions relevant to the data products posted here.
Free | 12 month subscription available.
Medisafe conducted a survey to global users during the beginning of the COVID-19 outbreak to assess the level of anticipated interruption with medication management routines and health management routines as a result of quarantine guidelines. This product includes three patients answers to a five questions survey, sent via the Medisafe App.
Price $24,000 | 12 month subscription available.
Examine daily medication consumption patterns of self-reported and de-identified patients taking medications from a cross-section of drug classes including antidiabetics DPP-4 Inhibitors and a combination of additional medications. The snapshot includes detailed breakdown of adherence/persistence data by medication, including overdosing, number and timeliness of missed doses and duration of medication intake.
Price $36,000 | 12 month subscription available.
Examine medication consumption patterns in granular, down to the hour, details of self-reported and de-identified patients taking Oncology- Neutropenia Inhibitors in combination with additional medications to gain insight about specific behaviors.
Price $36,000 | 12 month subscription available.
Gain actionable insights from self-identified reasons for non-adherence to a missed dose by patients self-report taking a combination of antidiabetic DPP-4 Inhibitors and/or additional medications . Assess and trend patient mindsets from the self-reported and de-identified Medisafe users indicating reasons for skipping specific doses from a complex medication regimen.
Price $25,000 | 1 month subscription available.
In October 2020, Medisafe deployed an in-app survey to patients to identify likeliness of getting COVID-19 vaccine when it comes to market and uncovered the concerns that patients have which vary by condition.
Price $25,000 | 36 month subscription available.
We asked people who use Medisafe to manage their medication regimen how they are coping with the coronavirus outbreak. This product includes their answers to a five questions survey, sent patients via the Medisafe App.
Price $36,000 | 12 month subscription available.
Gain actionable insights from identified reasons for non-adherence of Antidepressants: SNRIs. Assess and trend patient mindsets from the self-reported and de-identified Medisafe users indicating reasons for skipping their SNRI medications.
Price $36,000 | 12 month subscription available.
Examine medication consumption patterns in granular, down to the hour, details of self-reported and de-identified patients taking Opioid class medications to gain insight about specific behaviors.
Price $36,000 | 12 month subscription available.
Gain actionable insights from self-identified reasons for non-adherence to Opioid med schedules. Assess and trend patient mindsets from the self-reported and de-identified Medisafe users indicating reasons for skipping their Opioid medications.
showing 11 - 20